Medical Device Maker Broncus Gets Financial Breathing Room from IPO
堃博医疗从IPO中获得财务上的喘息

Investors are betting company can quickly ramp up sales for its core pulmonary devices, most of which have been approved or are near approval in China, the U.S. and Europe
投资者押注该公司能够迅速提高其核心肺部治疗设备的销售，其中大部分设备已经在manbetx3.0 、美国和欧洲获得批准或即将获得批准。